Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | HCID 59403542 | HCID 59403542 | — |
| Solvent | Diethylether ethylacetate | HCID 21584169 | — |
| Product | HCID 44128661 | HCID 44128661 | 34.5% |
Reaction Steps
1,1-Dimethylethyl [7-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1,3,4,5-tetrahydro-2H-2-benzazepin-2-yl]acetate (Preparation 8) (65 mg, 0.131 mmol) was treated with HCl (1305 μl, 5.22 mmol) (4N in dioxan) and left standing for 2 hours. The reaction mixture was then warmed at 50° C. for 1 hour then heated at 60° C. for a further 1.25 hours before solvent removal by evaporation. Trituration with ether/EtOAc failed and the material obtained was purified by MDAP. A white solid (20 mg) was obtained freeze drying appropriate MDAP fractions. Further drying under vacuum at 70° C. for 16 hours yielded the title compound (16 mg) as a solid. δH (400 MHz, d6DMSO) 1.36 (6H, d), 1.51-1.53 (2H, m), 2.98-3.00 (2H, m), 3.4 (2H, br.s), 4.10 (2H, s), 4.86-4.92 (1H, m), 7.32 (1H, d), 7.44 (1H, d), 7.83-7.88 (2H, m), 8.11 (1H, dd), 8.18 (1H, d); MS (ES) C23H2435ClN3O4 requires 441; found 442 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08222245B2 |
|---|
| Source dataset | uspto-grants-2012_07 |
|---|
| ORD ID | ord-a2e784f7627646a3a294e4ac23ed2f07 |
|---|
| Source note | uspto-grants-2012_07 |
|---|